**Registration for the ACR Convergence Program is required to participate in this live satellite. Please register at: https://www.rheumatology.org/Annual-Meeting/Registration
JAK inhibitors have established efficacy in the management of RA; however, clinicians and patients are uncertain about their place in therapy given recent safety concerns. Join us as expert faculty lead a robust discussion, highlighting the latest clinical trial and real-world evidence regarding JAK inhibitor efficacy and safety to help contextualize risks and apply practical mitigation strategies to comprehensive care plans.
This symposium is sponsored by Clinical Care Options, LLC and supported by a grant from Lilly USA, LLC. This is not an official program of the American College of Rheumatology.
1 upcoming events, beginning 11/14/2022More Information